These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 6957317)

  • 1. o-Methylation on anthracyclines and anthracyclinones. New o-methyl ethers of daunorubicin and its analogues.
    Cassinelli G; Di Matteo F; Forenza S; Ripamonti MC; Ruggieri D; Vigevani A; Arcamone F
    Farmaco Sci; 1982 Aug; 37(8):501-13. PubMed ID: 6957317
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New anthracycline glycosides: 4-O-demethyl-11-deoxydoxorubicin and analogues from Streptomyces peucetius var. aureus.
    Cassinelli G; Rivola G; Ruggieri D; Arcamone F; Grein A; Merli S; Spalla C; Casazza AM; Di Marco A; Pratesi G
    J Antibiot (Tokyo); 1982 Feb; 35(2):176-83. PubMed ID: 6951826
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytostatic activity of daunorubicin analogs containing daunosamine as furanoside.
    Kuszmann J; Medgyes G; Dvortsák P; Tory K
    Arzneimittelforschung; 1986 May; 36(5):786-9. PubMed ID: 3730013
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and biological activity of the two isomeric 2'-C-methyl daunomycins.
    Rocherolle V; Olesker A; Lukacs G
    J Antibiot (Tokyo); 1989 Sep; 42(9):1393-7. PubMed ID: 2793594
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New anthracycline glycosides obtained by the nitrous acid deamination of daunorubicin, doxorubicin and their configurational analogues.
    Cassinelli G; Ballabio M; Arcamone F; Casazza AM; Podesta' A
    J Antibiot (Tokyo); 1985 Jul; 38(7):856-67. PubMed ID: 3861603
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antitumor effect of selected daunorubicin derivatives in mice with P 388 leukemia.
    Kuśnierczyk H; Rak J; Radzikowski C
    Arch Immunol Ther Exp (Warsz); 1986; 34(3):259-62. PubMed ID: 3592929
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New N-amino acid derivatives of daunorubicin.
    Dzieduszycka M; Stefanska B; Borowski E; Martelli S
    Farmaco Sci; 1986 Nov; 41(11):881-91. PubMed ID: 3803566
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of the methylation of aglycone hydroxyl groups on the biological and biochemical properties of daunorubicin.
    Zunino F; Casazza AM; Pratesi G; Formelli F; DiMarco A
    Biochem Pharmacol; 1981 Jul; 30(13):1856-8. PubMed ID: 7271876
    [No Abstract]   [Full Text] [Related]  

  • 9. Chemosensitizers counteracting acquired resistance to anthracyclines and vinca alkaloids in vivo. A new treatment principle.
    Skovsgaard T; Danø K; Nissen NI
    Cancer Treat Rev; 1984 Mar; 11 Suppl A():63-72. PubMed ID: 6375864
    [No Abstract]   [Full Text] [Related]  

  • 10. Synthesis and antitumor activity of optically active (+)-9-O-alpha-L-daunosaminyl-4-demethoxydaunorubicin.
    Kimura Y; Matsumoto T; Suzuki M; Terashima S
    J Antibiot (Tokyo); 1985 Sep; 38(9):1277-9. PubMed ID: 4066509
    [No Abstract]   [Full Text] [Related]  

  • 11. [New anthracycline antibiotics and derivatives].
    Tatsuta K
    Gan To Kagaku Ryoho; 1984 Dec; 11(12 Pt 2):2640-52. PubMed ID: 6594977
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sugar-ring analogs of daunorubicin: 3'-epidaunorubicin, 3'-hydroxy-3',5'-diepidaunorubicin and 3',6'-dihydroxy-3',5'-diepidaunorubicin.
    Cheung TM; Horton D; Priebe W; Turner WR; Weckerle W
    J Antibiot (Tokyo); 1985 May; 38(5):683-6. PubMed ID: 4019314
    [No Abstract]   [Full Text] [Related]  

  • 13. Discovery of a daunorubicin analogue that exhibits potent antitumor activity and overcomes P-gp-mediated drug resistance.
    Fang L; Zhang G; Li C; Zheng X; Zhu L; Xiao JJ; Szakacs G; Nadas J; Chan KK; Wang PG; Sun D
    J Med Chem; 2006 Feb; 49(3):932-41. PubMed ID: 16451059
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and antileukemic activity of N-enamine derivatives of daunorubicin, 5-iminodaunorubicin, and doxorubicin.
    Stefańska B; Dzieduszycka M; Bontemps-Gracz M; Borowski E; Martelli S
    J Antibiot (Tokyo); 1988 Feb; 41(2):193-8. PubMed ID: 3356607
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antitumor activity of idarubicin, a derivative of daunorubicin, against drug sensitive and resistant P388 leukemia.
    Tsuruo T; Oh-Hara T; Sudo Y; Naito M
    Anticancer Res; 1993; 13(2):357-61. PubMed ID: 8517647
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and antitumor activity of 3'-C-methyl-daunorubicin.
    Thang TT; Imbach JL; Fizames C; Lavelle F; Ponsinet G; Olesker A; Lukacs G
    Carbohydr Res; 1985 Jan; 135(2):241-7. PubMed ID: 3986844
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytotoxicity, cellular uptake and DNA damage by daunorubicin and its new analogues with modified daunosamine moiety.
    Ciesielska E; Studzian K; Wasowska M; Oszczapowicz I; Szmigiero L
    Cell Biol Toxicol; 2005; 21(3-4):139-47. PubMed ID: 16328893
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of tunicamycin on anthracycline resistance in P388 murine leukemia cells.
    Chou TH; Kessel D
    Biochem Pharmacol; 1981 Nov; 30(22):3134-6. PubMed ID: 6950722
    [No Abstract]   [Full Text] [Related]  

  • 19. [Possibility of utilizing lymphatic leukemia L1210 as a first screening model in the primary selection of new antitumor antibiotics].
    Shorin VA; Bazhanov VS
    Antibiotiki; 1974 Aug; 19(8):679-84. PubMed ID: 4455117
    [No Abstract]   [Full Text] [Related]  

  • 20. Cytotoxic and mutagenic in vitro effect of 7-O-epoxyalkyl derivatives of daunomycinone. Part IX.
    Sturdíková M; Fusková A; Prikrylová V; Podojil M; Fuska J
    Neoplasma; 1986; 33(3):297-305. PubMed ID: 2426609
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.